Omalizumab Plus House Dust Mite Immunotherapy for Asthma: A Randomised, 5‐Arm, Non‐Blinded, Non‐Placebo‐Controlled, Multicentre, Interventional Trial

Authors

Institutions

Publication Details

Journal
Clinical & Experimental Allergy
Published
2025-02-23
DOI
https://doi.org/10.1111/cea.70021
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Omalizumab Plus House Dust Mite Immunotherapy for Asthma: A Randomised, 5‐Arm, Non‐Blinded, Non‐Placebo‐Controlled, Multicentre, Interventional Trial

Giorgio Walter Canonica, Andrzej Bożek, Alicja Grzanka
Clinical & Experimental Allergy
Allergic Rhinitis and Sensitization
article

Omalizumab Plus House Dust Mite Immunotherapy for Asthma: A Randomised, 5‐Arm, Non‐Blinded, Non‐Placebo‐Controlled, Multicentre, Interventional Trial

Giorgio Walter Canonica, Andrzej Bożek, Alicja Grzanka
article en

Abstract

No abstract available for this paper.
Clinical & Experimental AllergyVol. 55(3)
Humanitas University (IT), Medical University of Silesia (PL), University of Silesia in Katowice (PL)
Openalex Percentile: Top 93%
Allergic Rhinitis and Sensitization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.